BRCA2 and ovarian cancer: Given that any additional gene identified is likely to have lower penetrance than BRCA1 or BRCA2 e.g., in a large family with multiple breast/ovarian cancer cases (MS ≥ 40), it is unlikely that this will be the entire explanation for the pattern observed.